Shandong Xinhua Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ASPIRIN, with a corresponding US DMF Number 10730.
Remarkably, this DMF maintains an Active status since its submission on January 20, 1994, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 01, 2017, and payment made on January 03, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II